In untreated CLL, the leukemic clone accounts for the vast majority of circulating CD19+ B cells, whereas in HCs, CD19+ cells represent a polyclonal population of non-malignant B cells. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.